GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 805 filers reported holding GLAXOSMITHKLINE PLC in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,490,000 | -2.3% | 67,659 | -0.0% | 1.46% | -14.6% |
| Q3 2020 | $2,548,000 | -8.9% | 67,685 | -1.3% | 1.70% | -13.4% |
| Q2 2020 | $2,798,000 | +5.1% | 68,596 | -2.3% | 1.97% | -2.9% |
| Q1 2020 | $2,661,000 | -20.8% | 70,224 | -1.7% | 2.03% | +2.1% |
| Q4 2019 | $3,358,000 | -33.4% | 71,459 | -39.5% | 1.98% | -41.5% |
| Q3 2019 | $5,039,000 | +9.1% | 118,061 | +2.3% | 3.39% | +3.8% |
| Q2 2019 | $4,620,000 | +0.6% | 115,448 | +5.1% | 3.27% | -7.8% |
| Q1 2019 | $4,591,000 | +27.8% | 109,850 | +16.9% | 3.54% | +6.9% |
| Q4 2018 | $3,592,000 | -2.7% | 94,005 | +2.3% | 3.32% | +0.2% |
| Q3 2018 | $3,691,000 | +2.2% | 91,881 | +2.6% | 3.31% | -10.4% |
| Q2 2018 | $3,611,000 | -2.5% | 89,581 | -5.5% | 3.69% | +0.1% |
| Q1 2018 | $3,703,000 | +18.4% | 94,787 | +7.5% | 3.69% | +13.5% |
| Q4 2017 | $3,128,000 | – | 88,195 | – | 3.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |